IRIS
COLUCCIA, Mauro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.252
AS - Asia 2.575
EU - Europa 1.651
SA - Sud America 659
AF - Africa 111
OC - Oceania 4
AN - Antartide 1
Totale 11.253
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.178
SG - Singapore 1.028
CN - Cina 823
BR - Brasile 565
SE - Svezia 397
HK - Hong Kong 328
RU - Federazione Russa 260
IT - Italia 211
UA - Ucraina 206
DE - Germania 199
VN - Vietnam 151
FI - Finlandia 142
GB - Regno Unito 94
CI - Costa d'Avorio 80
IN - India 62
AR - Argentina 41
CA - Canada 35
ID - Indonesia 28
BD - Bangladesh 27
FR - Francia 27
MX - Messico 25
JP - Giappone 20
BE - Belgio 18
EC - Ecuador 18
ZA - Sudafrica 17
ES - Italia 16
IE - Irlanda 16
TR - Turchia 16
CZ - Repubblica Ceca 12
IQ - Iraq 12
IR - Iran 12
PL - Polonia 12
AT - Austria 10
CO - Colombia 10
JO - Giordania 10
PK - Pakistan 10
UZ - Uzbekistan 8
VE - Venezuela 8
NL - Olanda 7
LT - Lituania 6
PY - Paraguay 6
SA - Arabia Saudita 6
CL - Cile 5
TN - Tunisia 5
NP - Nepal 4
RO - Romania 4
AU - Australia 3
AZ - Azerbaigian 3
DO - Repubblica Dominicana 3
GE - Georgia 3
IL - Israele 3
JM - Giamaica 3
PE - Perù 3
PT - Portogallo 3
AL - Albania 2
BO - Bolivia 2
DZ - Algeria 2
HN - Honduras 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
MA - Marocco 2
OM - Oman 2
PS - Palestinian Territory 2
SI - Slovenia 2
SN - Senegal 2
SV - El Salvador 2
AE - Emirati Arabi Uniti 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CH - Svizzera 1
CR - Costa Rica 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
HR - Croazia 1
HU - Ungheria 1
KE - Kenya 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MD - Moldavia 1
MN - Mongolia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
QA - Qatar 1
RS - Serbia 1
TH - Thailandia 1
UY - Uruguay 1
Totale 11.253
Salva come PNG Salva come JPEG
Città #
Fairfield 634
Chandler 602
Woodbridge 576
Ashburn 515
Singapore 488
Jacksonville 461
Houston 370
Nyköping 327
Hong Kong 326
Seattle 268
Ann Arbor 255
Cambridge 244
Wilmington 212
Beijing 211
Nanjing 141
Bari 132
Lawrence 128
Roxbury 128
New York 124
Boardman 87
Des Moines 84
Abidjan 80
Dallas 74
Los Angeles 74
Ho Chi Minh City 64
Princeton 57
Inglewood 55
Brooklyn 42
Nanchang 42
Buffalo 40
Hebei 39
São Paulo 39
Helsinki 38
Santa Clara 36
Shenyang 33
Jiaxing 32
San Diego 32
Dearborn 29
Hanoi 27
Council Bluffs 25
Munich 25
Pune 23
Tokyo 20
Guangzhou 19
Tianjin 19
San Francisco 18
Brussels 17
Moscow 17
Dublin 16
Jakarta 15
Rio de Janeiro 15
Shanghai 15
Belo Horizonte 14
San Jose 14
Boston 13
Changsha 13
Columbus 13
The Dalles 13
Ardabil 12
Brasília 12
London 12
Toronto 12
Brno 11
Phoenix 11
Amman 10
Auburn Hills 10
Dong Ket 10
Johannesburg 10
Kunming 10
Leawood 10
Montreal 10
Mumbai 10
Washington 10
Chennai 9
Jinan 9
Ningbo 9
Salvador 9
Warsaw 9
Wuhan 9
Chicago 8
San Mateo 8
Santo André 8
Tashkent 8
Zhengzhou 8
Augusta 7
Curitiba 7
Quito 7
Redwood City 7
Ribeirão Preto 7
Stockholm 7
Wuxi 7
Ankara 6
Baghdad 6
Denver 6
Hefei 6
Jinhua 6
Norwalk 6
Orem 6
Paris 6
Porto Alegre 6
Totale 7.827
Salva come PNG Salva come JPEG
Nome #
Cyclooxygenase-1 (COX-1) and COX-1 Inhibitors in Cancer: A Review of Oncology and Medicinal Chemistry Literature 189
Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia 164
Effect of mofezolac-galactose distance in conjugates targeting cyclooxygenase (COX)-1 and CNS GLUT-1 carrier 163
Investigating Structural Requirements for the Antiproliferative Activity of Biphenyl Nicotinamides 161
The Challenge of Establishing Reliable Screening Tests for Selecting Anticancer Metal Compounds 159
Improving knowledge on the activation of bone marrow fibroblasts in MGUS and MM disease through the automatic extraction of genes via a nonnegative matrix factorization approach on gene expression profiles. 159
Cell Cycle Regulation by Ca2+-Activated K+ (BK) Channels Modulators in SH-SY5Y Neuroblastoma Cells 157
Effect of cisplatin containing liposomes formulated by unsaturated chain-containing lipids on gynecological tumor cells. 151
Novel targeting of phospho-cMET overcomes drug resistance and induces antitumor activity in multiple myeloma 146
Antimetastatic properties and DNA interactions of the novel class of dimeric Ru(III) compounds [Na]2{trans-RuCl4(Me2SO)]2(µ-L)} (L = ditopic, non-chelating aromatic N-ligand) 144
Mutagenic activity of some platinum complexes: chemical properties and biological activity 141
Effect of chirality in platinum drugs 132
Antitumor trans-platinum DNA adducts: NMR and HPLC study of the interaction between a trans-Pt(iminoether) complex and the deoxy decamer d(CCTCGCTCTC).d(GAGAGCGAGG) 130
Intelligent microarray data analysis through non-negative matrix factorization to study human multiple myeloma cell lines 129
Biologic activity of platiunum complexes with proflavine 127
Mutagenic activity of some platinum complexes with monodentate and bidentate amines 126
Endothelial cells in the bone marrow of patients with multiple myeloma 120
Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance 113
Platinum(II) based anticancer agents with a trans geometry 112
Biological activity of platinum complexes containing chiral centers on the nitrogen or carbon atoms of a chelate ring. 110
Antitumour platinum iminoether complexes 109
Efficacy of 5FU combined to Na[trans-RuCl4(DMSO)Im], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline, and MCa mammary carcinoma 108
ANTIBACTERIAL AND ANTICANCER ACTIVITY OF PLATINUM COMPLEXES WITH CHIRAL DIAMINES 107
Ruthenium-sulfoxide complexes with a specific antimetastatic activity 106
Anti-leukaemic action of RuCl2 (DMSO)4 isomers and prevention of brain involvement on P388 leukaemia and on P388/DDP subline 106
A preclinical overview on gold(III) compounds in the forefront of the targeted anticancer therapy. 105
Antitumour ruthenium(II)-dimethylsulfoxide complexes 105
Trans-Platinum Compounds in Cancer Therapy: A largely Unexplored Strategy for Identifying Novel Antitumor Platinum Drugs 104
null 104
Antitumor trans iminoether platinum di- and oligonucleotide adducts studied by NMR. 104
Platinum(II)-Acyclovir complexes of acyclovir: synthesis, antiviral and antitumor activity 104
Bone marrow fibroblasts provide a permissive microenvironement for multiple myeloma cells 103
Biological Activity of Platinum Complexes Containing Chiral Centers on the Nitrogen or Carbon atoms of a Chelate Diamine Ring. Inorg. Chim. Acta, 103
DNA binding specificity of the antitumor complexes cis- and trans-RuCl2(DMSO)4 determined by primer extension footprinting assay 103
Processo di sintesi di complessi di platino con imminoeteri e loro utilizzazione come agenti antitumorali e agenti modificanti le basi nucleotidiche 103
Antitumour platinum-iminoether complexes 102
Treatment with cyclosporin A does not affect macrophage procoagulant activity and plasminogen activator inhibitor in mice 102
Antitumour platinum iminoether complexes 101
Synthesis and in vitro antitumor activity of platinum acetonimine complexes 100
Antitumor active trans-platinum compounds 100
Bone marrow fibroblasts provide a permissive microenvironment for multiple myeloma cells. 98
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 97
Effect of isomerism at non-leaving ligands in platinum anticancer drugs 97
Antitumour activity and matrix metalloproteinase inhibition by platinum-diethyl{(methylsulfinyl)methyl}phosphonate complexes 96
Salivary up-regulation of human polymorphonuclear leucocyte chemotaxis and adhesion-molecule expression 94
Anttitumor activity of trans-platinum species 94
Antitumor activity of trans platinum complexes 94
CITOTOSSICITA' IN VITRO DI ALCUNI MATERIALI DENTALI 93
In vitro cisplatin effects on phagocyte functions 93
Mutagenic activity of transition metal complexes: relation structure-mutagenic and antibacterial activity for some Pd(II), Pt(II) and Rh(I) complexes 92
A Framework for Biological Data Normalization, Interoperability, and Mining for Cancer Microenvironment Analysis 92
null 92
Trans-Platinum Complexes in Cancer Therapy 91
Current Status of trans-Platinum Compounds in Cancer Therapy 91
null 88
Analisi dell’espressione genica (Dna Microarray) in cellule endoteliali e cellule tumorali dopo trattamento con il farmaco antimetastatico sperimentale Nami-A 87
Pharmacological action of the platinum-iminoether complex cis-[PtCl2{E-HN=C(OMe)}NH3] 86
Antiviral and antitumour properties of a platinum(II) complex with acyclovir 85
Cellular and biochemical properties of antitumour trans platinum-iminoether complexes 84
Gain-of-Function STIM1 L96V Mutation Causes Myogenesis Alteration in Muscle Cells From a Patient Affected by Tubular Aggregate Myopathy 84
Iminoethers as Carrier Ligands: A Novel trans-Platinum Complex Possessing in Vitro and in Vivo Antitumour Activity 83
Bone Marrow Fibroblasts and Multiple Myeloma Progression 82
Leading-edge gold(III) derivatives in targeted anticancer therapy: in vivo acute toxicity investigation and transcriptomic analysis of treatment-induced response in two human breast cancer cell lines. 82
Comparison of cytotoxicity, cellular accumulation and cell cycle modifications of cisplatin and trans-[PtCl2E(iminoether)2] in human and ovarian carcinoma cell lines 80
Breast Cancer's Microarray Data: Pattern Discovery Using Nonnegative Matrix Factorizations. 80
Effect of antitumor platinum compounds with trans geometry on the induction of cytotoxicity and cell cycle modifications 78
DIFFERENT BINDING TO DNA OF ENANTIOMERIC PLATINUM COMPLEXES ASSESSED BY INHIBITION OF RESTRICTION ENZYME-ACTIVITY 77
Complessi antitumorali di platino a geometria trans 76
Salivary up-regulation of PMN chemotaxis and adhesion molecules expression 74
Inibizione di metalloproteasi da parte di complessi di platino con analoghi bisfosfonati 74
Inhibition of endothelial cell function and angiogenesis by the metastasis inhibitor NAMI-A 74
A trans-platinum complex showing higher antitumor activity than the cis congeners 74
Cytotoxicity and DNA binding mode of new platinum iminoether derivatives with different configuration at the iminoether ligands 73
Na[trans-RuCl4(DMSO)Im]2DMSO: antimetastatic ruthenium 71
Platinum complexes with bisphosphonate analogue: a novel dual mechanism of antitumour action 71
Interaction of RuCl2 (dimethylsulphoxide)4 isomers with DNA 70
Water soluble ruthenium(III)-dimethylsulfoxide complexes: chemical behavior and pharmacological properties 70
Bone Marrow Fibroblasts and Multiple Myeloma Progression. 70
Mechanistic studies on platinum(II) complexes with iminoethers: a trans platinum antitumor agent. 70
Response of MCa mammary carcinoma to cisplatin and to Na(trans- Rucl4(DMSO)Im): Selective inhibition of spontaneous lung metastases by the ruthenium complex. 68
null 68
null 67
Ulteriori contributi allo studio dell'interazione cisplatino-DNA 66
MMP activity inhibition by platinum-diethyl[(methylsulfinyl)methyl]phosphonate (SMP) complexes” 66
null 66
Identification of genes associated with platinum iminoether compounds activity in ovarian cancer cells 65
null 65
Effects of trans-[PtCl2(NH3){Z-HN=C(OMe)Me}] (trans-Z) and Transplatin on cell-cycle progression and gene expression of SVOK-3 ovarian cancer cells 65
Complessi di platino a geometria trans: nuove strategie di scoperta e sviluppo di farmaci antitumorali di platino. 65
null 65
Screening tests for selecting anticancer metal compounds 62
Iminoethers as carrier ligands: a novel trans-platinum complex possessing in vitro and in vivo antitumor activity 62
A new generation of platinum anticancer complexes with trans geometry 62
In vitro effects of ruthenium complex [ImH][trans-RuCl4(DMSO)Im] on angiogenenic propreties of endothelial cells 62
Method for synthesizing complexes of platinum with iminoethers and their use as antitumoral drugs and nucleotide base modifiers 61
DNA interaction properties of platinum –iminoether complexes 60
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 59
Trans platinum complexes in cancer therapy: a largely unexplored strategy of identifying novel antitumour platinum drugs 58
DNA adducts of antitumor trans-[PtCl2(E-imimo ether)2] 58
The Bisphosphonate Zoledronic Acid Affects the Angiogenic Phenotype of Bone Marrow Endothelial Cells in Multiple Myeloma Patients 58
Totale 9.497
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021741 0 0 0 0 0 65 75 90 156 177 123 55
2021/2022787 21 121 1 30 32 33 32 35 44 49 156 233
2022/20231.524 217 144 123 145 196 202 6 194 233 11 22 31
2023/2024565 40 87 25 27 69 183 4 35 12 10 1 72
2024/20251.919 138 30 183 64 46 132 206 137 54 94 294 541
2025/20262.240 564 172 335 486 490 193 0 0 0 0 0 0
Totale 11.561